LEVBIO — Level Bio AB (publ) Share News
0.000.00%
- SEK19.43m
- SEK18.25m
- SEK32.36m
Brief: Alphahelix Molecular Diagnostics Q3 Result After Tax Swings To Profit Of SEK 0.2 Mln
Brief: AlphaHelix Delivers PCR-Based Rapid Test For Coronavirus To TATAA
Brief: AlphaHelix Signs Deal For COVID-19 Testing For PCR Detection
Brief: Alphahelix Q2 Result After Tax Rises To SEK 764,000
Brief: Alphahelix Molecular Diagnostics Appoints Mikael Havsjö CEO
Brief: AlphaHelix Delivers Laboratory Equipment And Consumables To Rojava
Brief: AlphaHelix: Mattias Molin Resigns As CEO
Brief: Alphahelix: Labkompaniet Sells 7 Mln Shares In Co
Brief: AlphaHelix Signs Deal With Sanimed International Impex
Brief: Alphahelix Molecular Diagnostics Q1 Result After Tax Swings To Profit Of SEK 837,000
Brief: Alphahelix Molecular Diagnostics Q4 Loss After Tax Narrows To SEK 0.6 Million
Brief: AlphaHelix Gets Renewed Cooperation Agreement With Karolinska Universitetssjukhusen
Brief: Alphahelix Molecular Diagnostics: Tataa Biocenter Chooses Rob
Brief: AlphaHelix Molecular Diagnostics Q3 Net Result Swings To Loss Of SEK 0.1 Mln
Brief: Alphahelix Molecular Diagnostics April-June Profit After Tax Up At SEK 54,000
Brief: Alphahelix Molecular Diagnostics Q1 Net Loss Narrows To SEK 351,000
Brief: Alphahelix Molecular Diagnostics July-Sept Net Result Swings To Profit Of SEK 0.2 Mln
Brief: AlphaHelix Molecular Diagnostics Makes Offer For Saveen & Werner
Brief: Alphahelix Molecular Diagnostics AB (Publ) Signs Distribution Agreements For United Kingdom And Malaysia